Eight pharmas win PBS listings

Posted 3 August 2026 AM

Eight companies have scored an August PBS listing and more than half of the winners are new drugs.

Among the newcomers is Chiesi’s Elfabrio, an enzyme replacement therapy for Fabry disease, and Servier Laboratories Voranigo, a dual inhibitor of IDH-1 and IDH-2, for the treatment of IDH-mutant astrocytoma or oligodendroglioma.

To see the whole article please log in.

Tiffany Walker

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

Retype password

Not a member? Sign up here